Literature DB >> 28250460

Rheumatoid Arthritis: Sirukumab effective in patients refractory to anti-TNF therapy.

Jessica McHugh.   

Abstract

Entities:  

Year:  2017        PMID： 28250460     DOI： 10.1038/nrrheum.2017.31

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Authors:  Daniel Aletaha; Clifton O Bingham; Yoshiya Tanaka; Prasheen Agarwal; Regina Kurrasch; Paul P Tak; Sharon Popik
Journal:  Lancet       Date:  2017-02-16       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.